Dr. Michael Grable, MD
What this data tells you about Dr. Grable
Dr. Michael Grable is an urology physician in Deland, FL, with 19 years in practice. Based on federal Medicare data, Dr. Grable performed 13,641 Medicare services across 2,775 unique beneficiaries.
Between the years covered by Open Payments, Dr. Grable received a total of $39,048 from 57 pharmaceutical and/or device companies across 398 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Grable is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, degarelix, 1 mg | 6,480 | $3 | $8 |
| Denosumab injection (Prolia/Xgeva) | 3,180 | $18 | $42 |
| Urinalysis with microscopic exam | 1,032 | $3 | $7 |
| Office visit, established patient (30-39 min) | 735 | $84 | $320 |
| Bladder ultrasound after voiding | 451 | $7 | $26 |
| Blood draw (venipuncture) | 340 | $6 | $6 |
| Office visit, established patient (20-29 min) | 289 | $53 | $227 |
| Chronic care management, first 20 min/month | 257 | $48 | $159 |
| Diagnostic exam of bladder and urethra using an endoscope | 115 | $158 | $610 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 107 | $24 | $81 |
| New patient office visit (45-59 min) | 86 | $110 | $422 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 85 | $135 | $336 |
| Automated urinalysis | 69 | $2 | $5 |
| Hospital follow-up visit, low complexity | 58 | $41 | $98 |
| Hospital follow-up visit, moderate complexity | 54 | $64 | $179 |
| Simple insertion of temporary bladder tube | 45 | $42 | $156 |
| Initial hospital admission, moderate complexity | 43 | $106 | $341 |
| Office visit, established patient (10-19 min) | 33 | $38 | $142 |
| Drug injection, under skin or into muscle | 31 | $11 | $35 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 26 | $342 | $1,061 |
| Insertion of stent in ureter using an endoscope | 23 | $116 | $396 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 19 | $236 | $809 |
| Ultrasound scan of pelvic region through rectum | 19 | $26 | $65 |
| Simple bladder irrigation and/or instillation | 18 | $26 | $193 |
| Imaging of urinary tract following injection of a contrast agent | 18 | $20 | $170 |
| Biopsy of prostate gland | 14 | $106 | $333 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 14 | $68 | $256 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (50%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 7% for urology physician in FL.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Grable is a mixed practice specialist, with above-average Medicare volume (top 9% in FL), and high industry engagement (consulting-driven, top 7%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Grable experienced with injection, degarelix, 1 mg?
Does Dr. Grable receive payments from pharmaceutical companies?
How do Dr. Grable's costs compare to other urology physicians in Deland?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology